Vicki Fellowes

2.0k citations

29 papers · 1.5k indexed · 1 hit paper · h-index 13

Co-authors: David F. Stroncek Ronald E. Gress James N. Kochenderfer Elizabeth J. Read Steven A. Feldman Maryalice Stetler‐Stevenson Irina Marić Jennifer N. Brudno
Topics: CAR-T cell therapy research (17 papers)Immunotherapy and Immune Responses (8 papers)Hematopoietic Stem Cell Transplantation (6 papers)
Cited by: Oncology Hematology Immunology
Journals: Blood Clinical Cancer Research British Journal of Haematology
Partner nations: United States United Kingdom Italy

In The Last Decade

Vicki Fellowes

29 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

2016 596 citations Syed Abbas Ali, Victoria Shi et al. Blood profile →

Peers

Countries citing papers authored by Vicki Fellowes

Since Specialization

Citations

This map shows the geographic impact of Vicki Fellowes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Fellowes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Fellowes more than expected).

Fields of papers citing papers by Vicki Fellowes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Fellowes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Fellowes. The network helps show where Vicki Fellowes may publish in the future.

Co-authorship network of co-authors of Vicki Fellowes

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Fellowes. A scholar is included among the top collaborators of Vicki Fellowes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Fellowes. Vicki Fellowes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CAR-T cell expansion platforms yield distinct T cell differentiation states 2024 ·Cytotherapy ·Hannah Song,Michaela Procházková,Lipei Shao,(unknown),Sarah Underwood,Mary A. Black,Vicki Fellowes,Rongye Shi,Marie Pouzolles,Hsien-Chao Chou,Adam Cheuk,Naomi Taylor,Ping Jin,Robert Somerville,David F. Stroncek,Javed Khan,Steven L. Highfill	28
2	Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia 2024 ·Molecular Therapy — Methods & Clinical Development ·(unknown),Katherine A. Weissler,Vicki Fellowes,Norris Lam,(unknown),(unknown),Steven L. Highfill,James N. Kochenderfer	2
3	Development of a closed system process for purifying naive CD8+ cells, culturing and transducing with a CD19/22 chimeric antigen receptor (CAR) to produce a clinical T memory stem cell product directed against B cell malignancies 2020 ·Cytotherapy ·Vicki Fellowes,Yihua Cai,(unknown),(unknown),Jianjian Jin,Steven L. Highfill,Dagmar Schneider,Boro Dropulić,D. Stroncek,Richard E. Gress,Luca Gattinoni	1
4	Deep and Durable Remissions of Relapsed Multiple Myeloma on a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain 2020 ·Blood ·Lekha Mikkilineni,Elisabet E. Manasanch,Danielle Vanasse,Jennifer N. Brudno,(unknown),Richard M. Sherry,Stephanie L. Goff,James Chih‐Hsin Yang,Norris Lam,Irina Marić,Maryalice Stetler‐Stevenson,Hao‐Wei Wang,Constance M. Yuan,David F. Stroncek,Steven L. Highfill,Vicki Fellowes,(unknown),Rashmika Patel,Steven A. Rosenberg,James N. Kochenderfer	14
5	Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use 2019 ·Journal of Translational Medicine ·Daniel S. Green,Ana T. Nunes,Kevin Tosh,(unknown),Vicki Fellowes,Jiaqiang Ren,Jianjian Jin,(unknown),(unknown),JoLynn Procter,(unknown),Irene Ekwede,Hanh Khuu,David F. Stroncek,Steven L. Highfill,Kathryn C. Zoon,Christina M. Annunziata	8
6	Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules 2018 ·Journal of Translational Medicine ·Jianjian Jin,Nikolaos Gkitsas,Vicki Fellowes,Jiaqiang Ren,Steven A. Feldman,Christian S. Hinrichs,David F. Stroncek,Steven L. Highfill	33
7	CD4 and CD8 T-cell positive selection increases the robustness of the CD22 CAR T-cell manufacturing process 2017 ·Cytotherapy ·Steven L. Highfill,Jianjian Jin,Vicki Fellowes,Jiaqiang Ren,Sneha Ramakrishna,Terry J. Fry,David F. Stroncek	2
8	CD4/CD8 T-Cell Selection Enhances CD22 CAR-T Cell Transduction and in-Vivo CAR-T Expansion: Updated Results on Phase I Anti-CD22 CAR Dose Expansion Cohort 2017 ·Blood ·Nirali N. Shah,Steven L. Highfill,Haneen Shalabi,Bonnie Yates,(unknown),Vicki Fellowes,(unknown),Jiaqiang Ren,Jianjian Jin,David F. Stroncek,Terry J. Fry	6
9	T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myelomabreakdown → 2016 ·Blood ·Syed Abbas Ali,Victoria Shi,Irina Marić,Michael Wang,David F. Stroncek,Jeremy J. Rose,Jennifer N. Brudno,Maryalice Stetler‐Stevenson,Steven A. Feldman,Brenna Hansen,Vicki Fellowes,Frances T. Hakim,Ronald E. Gress,James N. Kochenderfer	596
10	Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells 2013 ·Cytotherapy ·Luciano Castiello,Miriam E. Mossoba,(unknown),Marianna Sabatino,Vicki Fellowes,Jason Foley,(unknown),David Halverson,Sara Civini,Ping Jin,Daniel H. Fowler,David F. Stroncek	2
11	Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer 2011 ·Clinical Cancer Research ·Nancy M. Hardy,Miriam E. Mossoba,Seth M. Steinberg,Vicki Fellowes,Xiaoyi Yan,Frances T. Hakim,Rebecca Babb,Daniele Avila,Juan Gea‐Banacloche,Claude Sportès,Bruce L. Levine,Carl H. June,(unknown),Ashley Carpenter,Michael Krumlauf,Andrew J. Dwyer,Ronald E. Gress,Daniel H. Fowler,Michael Bishop	12
12	Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies 2011 ·Biology of Blood and Marrow Transplantation ·Stephan Mielke,(unknown),Aarthi Shenoy,Vicki Fellowes,(unknown),David F. Stroncek,Susan F. Leitman,Richard Childs,Minoo Battiwalla,(unknown),(unknown),Bipin N. Savani,(unknown),A. John Barrett	34
13	Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome 2011 ·Biology of Blood and Marrow Transplantation ·(unknown),(unknown),(unknown),(unknown),Gerrit Weber,Vicki Fellowes,(unknown),David Stroncek,Susan F. Leitman,Minoo Battiwalla,A. John Barrett	25
14	Successful Translation of a GMP-Based, Clinical Scale Selective Allodepletion Approach for Matched Donor-Recipient Pairs from Bench-to-Bedside. 2007 ·Blood ·Stephan Mielke,Raquel Nunes,Katayoun Rezvani,Vicki Fellowes,(unknown),Scott R. Solomon,Yong Fan,Christian Scotto,Elizabeth J. Read,A. John Barrett	1
15	High Efficiency Clinical Scale Selective Depletion of Alloreacting T Cells Using Expanded T Lymphocytes as Antigen-Presenting Cells and a TH9402-Based Photodepletion Technique in HLA-Mismatched and Matched Donor-Recipient Pairs. 2006 ·Blood ·Stephan Mielke,Raquel Nunes,Katayoun Rezvani,Vicki Fellowes,Yong Fan,Scott R. Solomon,Christian Scotto,Elizabeth J. Read,A. John Barrett	2
16	Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells 2005 ·NMR in Biomedicine ·Ali S. Arbab,Gene T. Yocum,Ali M. Rad,Aarif Y. Khakoo,Vicki Fellowes,Elizabeth J. Read,Joseph A. Frank	246
17	Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals 2005 ·Human Gene Therapy ·Richard A. Morgan,Robert Walker,Charles S. Carter,Ven Natarajan,Jorge A. Tavel,(unknown),(unknown),Linda Muul,(unknown),Shyla Jagannatha,Bruce A. Bunnell,Vicki Fellowes,Julia A. Metcalf,Randy Stevens,Michael Baseler,Susan F. Leitman,Elizabeth J. Read,R. Michael Blaese,H. Clifford Lane	2
18	Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals 2005 ·Human Gene Therapy ·Richard A. Morgan,Robert Walker,Charles S. Carter,Ven Natarajan,Jorge A. Tavel,(unknown),(unknown),Linda Muul,Zhili Zheng,Shyla Jagannatha,Bruce A. Bunnell,Vicki Fellowes,Julia A. Metcalf,Randy Stevens,Michael Baseler,Susan F. Leitman,Elizabeth J. Read,R. Michael Blaese,H. Clifford Lane	55
19	Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution? 2000 ·Cytotherapy ·Anne Husebekk,Vicki Fellowes,E.J. Read,(unknown),(unknown),Ronald E. Gress,Daniel H. Fowler	3
20	Fas‐mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous FasL‐expressing T cells 1999 ·British Journal of Haematology ·(unknown),(unknown),(unknown),Anne Husebekk,Vicki Fellowes,Elizabeth J. Read,Ronald E. Gress,Daniel H. Fowler	23

About Vicki Fellowes

Vicki Fellowes is a scholar working on Immunology, Oncology and Hematology, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (8 papers) and Hematopoietic Stem Cell Transplantation (6 papers). The work is most often cited by research in Oncology (1.0k citations), Hematology (326 citations) and Immunology (510 citations). Vicki Fellowes has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include David F. Stroncek, Ronald E. Gress, James N. Kochenderfer, Elizabeth J. Read, Steven A. Feldman, Maryalice Stetler‐Stevenson, Irina Marić, Jennifer N. Brudno, Brenna Hansen and Victoria Shi. Their work appears in journals such as Blood, Clinical Cancer Research and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact